Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijmmb.2021.09.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phenotypic and genotypic characterization of clinical carbapenem-resistant species harboring the metallo-beta-lactamases IMP-8 or NDM-1 in China.
Microbiol Spectr
December 2024
Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China.
Unlabelled: Carbapenem-resistant spp. pose a significant challenge in clinical settings due to limited treatment options for nosocomial infections. Carbapenem-hydrolyzing class D beta-lactamases are the primary cause for carbapenem resistance, while metallo-beta-lactamases (MBLs) New Delhi metallo beta-lactamase (NDM) and imipenemase (IMP) also contribute.
View Article and Find Full Text PDFAntimicrobial Resistance Pattern, Predisposing Factors, and Outcome of Serratia Infection in Patients Treated at a Secondary-Care Hospital in Oman: A 5-Year Retrospective Study.
Adv Biomed Res
October 2024
Department of Community Medicine, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India.
Background: has emerged as an important nosocomial opportunistic pathogen, often associated with serious infections. We investigated the antimicrobial resistance trends, predisposing factors, and infection outcomes associated with isolated in a secondary-care hospital in Oman.
Materials And Methods: A retrospective study was conducted at a secondary-care hospital in the northern region of Oman after receiving approval from the research ethics and approval committee of Oman.
Phenotypic Profiling of Tigecycline-resistant Klebsiella pneumoniae Strains Induced In vitro.
Curr Microbiol
December 2024
Medical School of Chinese PLA, Beijing, China.
Tigecycline is one of the last-resort treatment options for infections caused by carbapenem-resistant Klebsiella pneumoniae (KP). Unfortunately, tigecycline resistance is increasingly reported and causes an unprecedented public health crisis worldwide. Although studies on tigecycline resistance are expanding, the underlying mechanisms are not fully understood.
View Article and Find Full Text PDFWhole-Genome Analysis of Multidrug-Resistant Klebsiella pneumoniae Kp04 Reveals Distinctive Antimicrobial and Arsenic-Resistance Genomic Features: A Case Study from Bangladesh.
Curr Microbiol
November 2024
Department of Genetic Engineering and Biotechnology, University of Chittagong, Chattogram, Bangladesh.
Article Synopsis
- Multidrug-resistant bacteria, especially ESBL-producing strains like Klebsiella pneumoniae, are a major global health threat, with this study focusing on Kp04, a clinical isolate from Bangladesh.
- The investigation revealed high antibiotic resistance, with five isolated K. pneumoniae strains being resistant to 14 out of 21 tested antibiotics while only being sensitive to three specific ones.
- Whole-genome sequencing of Kp04 identified 75 genes associated with ESBL, virulence, and multiple drug resistance, highlighting similarities in virulence and resistance among isolates from Dhaka and Chattogram, indicating possible transmission of these strains in the region.
NDM-1 and KPC-3 co-producing Klebsiella pneumoniae ST512 in bronchial secretion from a patient in an intensive care unit of a Greek Tertiary Care Hospital.
Acta Microbiol Immunol Hung
December 2024
3Hippokration General Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.
This study investigated a strain of Klebsiella pneumoniae, identified as GRTHES, which exhibited extensive antibiotic resistance. The strain was resistant to all beta-lactams, including combinations with newer agents such as meropenem/vaborbactam and imipenem/relebactam, as well as to aminoglycosides, fluoroquinolones, fosfomycin, trimethoprim-sulfamethoxazole and colistin. It remained susceptible to tigecycline.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!